These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10066211)

  • 1. Fortnightly review: Intracoronary stents.
    Gandhi MM; Dawkins KD
    BMJ; 1999 Mar; 318(7184):650-3. PubMed ID: 10066211
    [No Abstract]   [Full Text] [Related]  

  • 2. What physicians should know about coronary stents.
    Rihal CS
    Minn Med; 2008 Jan; 91(1):44-6. PubMed ID: 18269069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid dissolution of intracoronary thrombus with eptifibatide therapy in a patient with post-infarction angina.
    Runyon JP; Snavely DD
    J Invasive Cardiol; 2000 Dec; 12 Suppl D():5D-7D. PubMed ID: 11156713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 5. Are stenting and glycoprotein IIb/IIIa blockade of good value in primary percutaneous coronary intervention?
    Cole JH; Weintraub WS
    Circulation; 2003 Dec; 108(23):2831-3. PubMed ID: 14662689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombosis of a coronary stent after discontinuing treatment with clopidogrel].
    van Werkum JW; Heestermans AA; Jaarsma W; Hautvast RW; de Boer MJ; ten Berg JM
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):863-8. PubMed ID: 16676518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of marker wire for intracoronary stenting.
    Oda H; Miida T; Toeda T; Higuma N
    Cathet Cardiovasc Diagn; 1996 Apr; 37(4):447-51. PubMed ID: 8721702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal stenting: does it make sense?
    Hodgson JM
    Cathet Cardiovasc Diagn; 1997 Oct; 42(2):137. PubMed ID: 9328694
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting versus bare-metal coronary stents: where are we now?
    Amoroso NS; Bangalore S
    J Comp Eff Res; 2012 Nov; 1(6):501-8. PubMed ID: 24236469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary stenting: an overview for the clinician.
    Marso SP; Ellis SG; Raymond R
    Cleve Clin J Med; 1999; 66(7):434-42. PubMed ID: 10410442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents for ST-segment elevation myocardial infarction: treatment of choice or is discretion the better part of valor?
    Rihal CS
    JACC Cardiovasc Interv; 2008 Jun; 1(3):233-5. PubMed ID: 19463305
    [No Abstract]   [Full Text] [Related]  

  • 12. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
    Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E
    JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel under scrutiny.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):925-6. PubMed ID: 19016464
    [No Abstract]   [Full Text] [Related]  

  • 15. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 16. Late bare-metal stent thrombosis in a patient with Crohn's disease.
    Yazıcı HU; Birdane A; Nadiradze A; Ünalır A
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):462-4. PubMed ID: 21733786
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of acute coronary syndromes: an update.
    Fox KA
    Heart; 2004 Jun; 90(6):698-706. PubMed ID: 15145891
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: incidence, predictors and clinical outcome.
    Heestermans AA; van Werkum JW; Zwart B; van der Heyden JA; Kelder JC; Breet NJ; van't Hof AW; Dambrink JH; Koolen JJ; Brueren BR; Zijlstra F; ten Berg JM
    J Thromb Haemost; 2010 Nov; 8(11):2385-93. PubMed ID: 20831622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.